These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
648 related items for PubMed ID: 4213265
21. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin. Ruiz-Palacios GM, Ponce de Leon S, Sifuentes J, Ponce de Leon S, Calva JJ, Huazano F, Ontiveros C, Ojeda F, Bobadilla M. Am J Med; 1986 Jun 30; 80(6B):71-5. PubMed ID: 3089006 [Abstract] [Full Text] [Related]
27. A laboratory assessment of the activities of four aminoglycosides. Schrire L, Robinson RG, Koornhof HJ. S Afr Med J; 1984 Jun 09; 65(23):922-4. PubMed ID: 6427946 [Abstract] [Full Text] [Related]
32. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use. Noone P. Drugs; 1984 Jun 09; 27(6):548-78. PubMed ID: 6376062 [Abstract] [Full Text] [Related]
34. In vitro evaluation of a new aminoglycoside derivative of kanamycin, a comparison with tobramycin and gentamycin. Ries K, Levison ME, Kaye D. Antimicrob Agents Chemother; 1973 Apr 09; 3(4):532-3. PubMed ID: 4790607 [Abstract] [Full Text] [Related]
35. Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics. Price KE, Pursiano TA, DeFuria MD. Antimicrob Agents Chemother; 1974 Feb 09; 5(2):143-52. PubMed ID: 4209522 [Abstract] [Full Text] [Related]
36. Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria. Seligman SJ. Antimicrob Agents Chemother; 1978 Jan 09; 13(1):70-3. PubMed ID: 626492 [Abstract] [Full Text] [Related]